top of page
Research & Technology
Wound care backed by research and created with cutting edge technology.
At BioLab, innovation is a vital driving point of the research we do. Our dedicated Research & Development (R&D) team brings scientists, engineers, and clinical experts together who are passionate about transforming wound care through cutting-edge biotechnology.
We specialize in the development and manufacturing of placental amnion, a clinically effective skin substitute used in advanced wound healing. Every product is designed with precision and manufactured under rigorous quality standards to ensure safety, consistency, and optimal patient outcomes.
Beyond our flagship amnion products, our internal R&D team drives the discovery and development of novel therapeutics that are not only groundbreaking but also FDA-cleared. By integrating biomaterials science with regenerative medicine, we are redefining what’s possible in tissue repair and chronic wound management.
With a focus on scientific excellence and real-world impact, our mission is clear: to deliver innovative, biologically derived solutions that accelerate healing and restore quality of life.
Research
Team
Our Research Department operates as a global intelligence and discovery engine. Rather than conducting benchwork internally, our team of expert analysts continuously survey the international wound care landscape to identify transformative technologies, emerging therapies, and breakthrough innovations. We strategically evaluate opportunities with the potential to reshape the future of wound healing and bring them into our pipeline.
Product
Development
The Product Development team at BioLab is where innovation becomes reality. Staffed by a multidisciplinary group of engineers and specialists, our team takes bold concepts and transforms them into FDA-cleared therapeutics and market-ready solutions. We collaborate with the world's leading Contract Research Organizations (CROs) to ensure that each product is developed with the level of precision, safety, and efficacy. From design to validation, our development process is built to deliver the next generation of wound care technologies.
Our Licensing & Registration
Canada CTO100258 Registration EXP 12.31.2026
Oregon Health Registry EXP 08.11.2027
Maryland Tissue Bank Permit NON-EXPIRING
FDA Registration EXP 08.31.2026
Our Licensing & Registration
Canada CTO100258 Registration EXP 12.31.2026
Canada CTO100258 Registration EXP 12.31.2026
Canada CTO100258 Registration EXP 12.31.2026
Canada CTO100258 Registration EXP 12.31.2026
Oregon Health Registry EXP 08.11.2027
Maryland Tissue Bank Permit NON-EXPIRING
Dr. Encinas
Dr. Carlos Encinas is the Chief Science Officer at BioLab, joining in January 2020 with over 20 years of experience in technology transfer and commercialization of research innovations. He has managed early-stage tech companies and represented research institutions internationally. Dr. Encinas holds a Bachelor's in Biotechnology Engineering, an MBA, and a Ph.D. in Molecular Biology from the University of Arizona.
Dr. Medley
Dr. Marshall Medley is the Chief Medical Officer at BioLab, joining in July 2022 with over 20 years of experience in vascular surgery and wound care. In his role, he helps oversee the company’s clinical direction, guiding product development and medical strategy to ensure patient-centered, evidence-based solutions. He has served as Medical Director at two wound care centers and practiced in multiple hospitals across southeast Michigan. Dr. Medley holds a BA in Biology, a Doctor of Osteopathic Medicine degree, and completed both a General Surgery Residency and a Vascular Surgery Fellowship.
Clinical Trials
BioLab Holdings Optimized Management of Chronic Diabetic Foot Ulcer with SkinSubstitute Therapy and Multidisciplinary Care
Dr. Carlos Encinas
Chief Science Officer
Dr. Carlos Encinas serves as the Chief Science Officer at Biolab, where he oversees the research team and drives innovation through collaborative research and development. His role is pivotal in ensuring high-value products by guiding scientific strategy and fostering cutting-edge ideas within the organization.
Since joining Biolab Holdings in January 2020, Dr. Encinas has brought over two decades of expertise in technology transfer, with a strong focus on identifying, protecting, and commercializing inventions emerging from academic and private research institutions. His career has included managing early-stage, technology-based companies and representing research centers on an international stage, particularly across Europe and South America.
Dr. Encinas holds a Bachelor's Degree in Biotechnology Engineering from the Technology Institute of Sonora, an MBA in Business Administration, and a Ph.D. in Molecular Biology from the University of Arizona; bringing a rare blend of scientific depth and business acumen to his leadership at Biolab Holdings.
Dr. Weston Quinn
Product Developer and Analyst
As a Product Development Scientist and Analyst specializing in wound care, Dr. Quinn is dedicated to seeking out innovative technologies that are revolutionizing the field. Internally, he collaborates with cross-functional teams to build high-impact wound care solutions, conducting rigorous analysis of, clinical data, and product performance to ensure optimal efficacy and safety. His focus remains on upholding the highest quality standards, driving iterative improvements that enhance patient outcomes and set new benchmarks in healthcare innovation.
Christian Swonger
Product Research and Development Associate
As a Product Research and Development Associate at BLH, Christian’s role is to identify and evaluate novel technologies that support patients through the wound healing process. His goal is to support BLH in becoming a "one-stop shop" for wound care. Furthermore, he strives to identify innovative technology outside of wound care to support portfolio expansion. Internally, Christian leads and supports study designs and analysis for studies. The focus is to communicate these revolutionary technologies with cross-functional teams so that BLH can provide the highest quality products in and outside of wound care.
bottom of page